ABSTRACT The chondroitin sulfate proteoglycan (PG) PG-M/versican is known to be a primary component of the vertebrate embryonic extracellular matrix and, in the mouse, functional abrogation of the versican gene leads to severe cardiovascular malformations and embryonic lethality. In order to provide a means for approaching the study of the role of versican during embryogenesis, we have cloned the Xenopus versican cDNA and we have performed in situ hybridization on embryos at different stages of development. We showed maternal Xversican transcription, as well as a previously undocumented early expression of the PG during gastrulation and neurulation. At later stages of development, spatial transcription of Xversican correlates with the patterns of migrating neural crest cells (NCC) and it is expressed in embryonic regions representing the final sites of arrest of NCC. Xversican mRNA was also detected in a subpopulation of trunk NCC migrating into the fin, in tissues flanking the trunk NCC ventral migratory pathway and in post-migratory cranial skeletogenic NCC. Further embryonic sites expressing Xversican were the pronephros, pronephric ducts, heart anlage and branchial pouches. These findings constitute the basis for future studies aimed at clarifying unresolved aspects of versican function during embryogenesis.
four extracellular matrix (ECM) PGs of the hyalectan subgroup. In versican, two different GAG attachment domains have thus far been identified in higher vertebrates and denoted GAGα and GAGβ. Both domains (exons) are present within the parental V0 isoform while they are differentially spliced out in isoforms V1 and V2 (Zimmermann and Ruoslahti, 1989; Shinomura et al., 1993) .
The complex structure of versican provides the basis for its multiple and sometime contrasting effects on cellular functions, such as cell adhesion, cell migration, cell proliferation and apoptosis, as well as on morphogenesis. For instance, in the nervous system, versican seems to mainly act as barrier molecule affectAbbreviations used in this paper: CRP, complement regulatory protein; ECM, extracellular matrix; EGF, epidermal growth factor; GAG, glycosaminoglycan; NCC, neural crest cell; PG, proteoglycan.
ing axon growth, cell migration and plasticity and these functions appear to be performed through its GAG chains (Schmalfeldt et al., 2000; Bradbury et al., 2002; Wu et al., 2005; Cattaruzza and Perris, 2006) .
A first evidence of a crucial role of versican during embryogenesis derives from the finding that the heart defect (hdf) mouse is a recessive lethal one that has arose from a transgene insertional mutation in the versican gene causing its almost complete abrogation. Embryos homozygous for the transgene die in utero by embryonic day 10.5 and exhibit specific defects along the cardiac axis (Mjaatvedt et al., 1998) . Intringuingly, this phenotype very closely resembles that exhibited by the hyaluronan synthase 2 (Has2) knock-out mouse (Camenisch et al., 2000) and, accordingly, has thus far not allowed to fully dissect the functional role of the PG during development. However, previous studies have underscored a crucial role of isoforms V0 and V1 during trunk neural crest cell (NCC) migration suggesting a chemorepulsive function (Landolt et al., 1995; Dutt et al., 2006) . Other investigations propose instead that versican is a component of the ECM of NCC pathways controlling directionality of cell movement through a mechanism of "inverse haptotaxis" (Perris, 1997; Perissinotto et al., 2000; Perris and Perissionotto, 2000) , consistent with previous findings in the white mutant axolotl embryo harbouring a genetic deficiency in versican expression (Stigson et al., 1997; Perris and Perissinotto, 2000) . Because the importance of versican during development, we decided to address its role by using Xenopus laevis embryo as model system.
We have previously determined the expression pattern of the Xenopus Has genes (Nardini et al., 2004) and we have shown that Has2 is widely expressed during development and is implicated in somitogenesis and precursor cell migration (Ori et al., 2006) .Since hyaluronan is one of the main versican binding partners we asked whether the versican gene expression is spatiotemporally coordinated with that of Has2.
In the present work we cloned the full length Xenopus versican cDNA (V0) and analyzed its expression pattern during embryogenesis.
Results

Xversican cloning
In the present study the full-length versican cDNA (V0) was identified in Xenopus laevis embryos (st. 30) as a sequence of 11.559 bp, codifying a putative core protein of 3852 amino acids. The comparison of the aminoacid sequence with that of other vertebrate orthologues shows the typical structure of the versican core protein composed of a G1 hyaluronan-binding domain, flanked by the two well-described GAG attachment regions, GAGα and GAGβ, and the multimodular G3 domain embodying an EGF repeat, lectin-like module and a CRP repeat. Whereas the G1 and G3 domains of Xversican show high homology (from 71% in the hyaluronan-binding G1 domain to 92% in the lectin-like region) with the human versican the homology drastically decreases in the GAGα and GAG β domains (19.5% compared with the human versican aminoacid sequence). Moreover, the Xversican GAGα and GAGβ domains appear 16% longer than the corresponding human regions. In addition to the full length V0 isoform we identified spliced variants corresponding to the isoforms V1, V2 and V3 (the corresponding nucleotide sequences have been submitted to GenBank with the following accession numbers: V0: 
Xversican mRNA expression during embryogenesis
In order to detail the Xversican spatio-temporal gene expression during development we performed in situ hybridization experiments using an antisense RNA digoxigenin labelled probe designed to bind the G3 domain of the Xversican mRNA.
Xversican transcripts were first detected at blastula stage (st. 6) in the animal pole blastomeres suggesting that it corresponds to a maternal transcript (Fig. 1A ). Zygotic Xversican expression was then detected at early gastrula stage (st. 10.5) in the presumptive axial mesoderm fated to form the notochord during gastrulation (st. 12.5; Fig. 1B, C) . Starting from midneurula Xversican expression becomes clearly detectable in the paraxial mesoderm and anteriorly in the eye field (Fig. 1D , D'). Coronal sections of the same stage embryos revealed Xversican expression in the notochord and in the medio-ventral domain of the neural plate ( Fig. 1D") . At late neurula stage (st. 18) labelling was detectable in premigratory cells of the trunk NCC and in the lateral, non-segmented plate mesoderm ( Fig.  1E ). At stages 22, Xversican expression appeared in the cardiac field, in the pronephros and in two symmetrical lateral strips, corresponding to the pronephric ducts (Fig. 1F ). Sagittal sections of the same stage embryos revealed a down-regulation of Xversican mRNA in the forming somites, while a signal was still detectable in the floor plate of the neural tube (Fig. 1F' ).
Xversican expression in the branchial arches
Starting from tailbud stages (st. 26), Xversican mRNA was observed in the branchial arches ( Fig. 2A, A' , A"). Horizontal sections show that, at this stage, Xversican expression is restricted to the endodermal component of the branchial pouches ( Fig. 2A'' ). At stage 37, after the completion of NCC migration, Xversican mRNA is expressed by the cranial neural crest component of the branchial arches, being organized in a pattern reminiscent to that of XSox9, a specific skeletogenic cranial NCC marker (Fig. 2B, B' , B''). This pattern of Xversican expression is very similar to that one previously observed for XHas2 (Nardini et al., 2004) . Accordingly, in later stages of larval development (st. 41), Xversican is expressed in chondrogenic precursor cells forming the visceral skeletal elements, as confirmed by comparing Xversican expression with that of XSox9 (Fig. 2C, C', C'' ). On the whole, Xversican transcript expression in the branchial arches overlaps that of XHas2, which appears first in the endodermal component of the pouches and subsequently in the cranial NCC chondrogenetic precursors (unpublished results), while both genes are absent in migrating cranial NCC (cf. Nardini et al., 2004) .
Xversican is produced by a subset of trunk NCC
At tailbud stage Xversican expression is detectable in a subpopulation of cells migrating into the fin (Fig. 3) . From stage 25-26 onwards Xenopus trunk NCC initiate their migration along two major pathways: a dorsal and a ventral pathway (Krotoski et al., 1988; Collazo et al., 1993, see Fig. 3A) . Dorsally migrating ones reach the dorsal fin and then migrate around the tail tip and along the ventral fin (Fig. 3B, C) . It has been suggested that these cells might contribute to the dorsal and ventral fin structures (Collazo et al., 1993) . As Xversican is present in trunk premigratory NCC we would like to suggest that dispersed Xversican positive cells within the dorsal and ventral fin may represent dorsally migrating NCC. The ventral migratory pathway is divided in two different routes, the majority of NCC migrate between the neural tube, somites and notochord, while a minor lateral pathway is formed by NCC moving underneath the ectoderm lateral to the neural tube (cf. Fig. 3A ). These populations of migrating trunk NCC do not appear to transcribe Xversican.
It is interesting to note that premigratory trunk NCC express Xversican (from st. 19) as well as XHas2 mRNA (Nardini et al., 2004) , whereas from stage 26 onwards Xversican seems to be only synthesized by a subpopulation of trunk NCC migrating along the dorsal pathway (Fig. 3B, C, D) . It remains to be clarified whether Xversican gene expression may identify a premigratory subset of NCC that are destined to specifically migrate along the dorsal pathway, or whether all precursors cells are initially able to produce versican but only a subpopu- (Fig. 3D, D' ).
Xversican expression in mesodermal derivatives
From stage 26 onwards, Xversican transcript also appears in the presomitic mesoderm of the tailbud and in the heart anlage ( Fig. 3B, C, C' ). Along the body axis, Xversican mRNA shows a metameric distribution following a rostral-to-caudal sequence of somites (Fig. 3B ). This pattern was analogous to that previously reported in the chick embryo (Perris et al., 1996; Landolt et al., 1995; Perissinotto et al., 2000) . Serial transverse and horizontal sections of embryos previously subjected to whole-mount in situ hybridisation, were stained with the 12/101 antibody to reveal muscle cells, such as to allow to define the Xversican transcript expression pattern in this embryonic region in more in detail. At stage 26 only posterior somites appeared labelled in their ventromedial (sclerotomic) portion, whereas no expression could be detected in anterior somites (Fig. 3C) . The hybridization signal was also present around the neural tube and the notochord, where sclerotome cells gradually spread (Fig. 3C' , C'', C'''). This expression pattern very close resembles the ventral migratory pathway and, similarly to what has been previously shown in chick embryo, Xversican mRNA may be transcribed by tissues flanking the NCC migratory pathways .
Discussion
In this study we show that Xversican is early and dynamically expressed during Xenopus embryogenesis. Somewhat unexpectedly Xversican seems to be a maternal gene and the PG is expressed early on in the axial mesoderm of the gastrulating embryo. Of particular interest is also to note the concomitant expression of Xversican with that of XHas2 in the presomitic mesoderm during neurulation, a stage in which the activity of the synthase is critical to prevent myoblasts from undergoing apoptosis (Ori et al., 2006) . It is therefore intriguing to envision a synergic role of hyaluronan and versican in structuring the ECM surrounding myoblasts during this critical step of myogenesis. Notably, both XHas2 and the Xversican gene are down-regulated as myogenesis proceeds during the antero-posterior segmentation of the presomitic mesoderm.
Later in development versican appears to represent a synthetic product of a subset of cells located in the dorsal and ventral fin that are likely trunk NCC dorsally migrating. For obvious reasons, this population has not a counterpart in chick or mouse embryos and probably represents a phylogenetically older trunk NCC subpopulation that in amphibia has the putative function of structuring the interstitial ECM of the fin or to give rise to presumptive secretory cells as suggested by Collazo and colleagues (1993) . Trunk NCC migrating ventrally do not express Xversican, but it is likely that Xversican deposition in the ECM through which they migrate may be implicated in their guidance, as previously described in the chick and axolotl embryos. Identification of Xversican gene now opens the possibility to clarify in a different model the highly debated role (not readily resolvable in mammals) of versican in NCC migration Dutt et al., 2006) , thanks to the possibility to more precisely manipulate its expression in the embryo by means of gene loss of function experiments.
Cranial NCC of the branchial arches do similarly not express Xversican during their migratory phase, but Xversican transcrip- 
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D' D C'' C' C tion occurs at their final site of arrest, i.e. in the pharyngeal pouches of the early tailbud embryo. Xversican expression is then detected in the NC-derived chondrogenic precursors giving rise to the skeletal components of the branchial arches. This pattern of expression of the PG largely overlaps with that of XHas2, suggesting that the functional relationship between hyaluronan and versican is initiated early on during embryonic development and may also be crucial for cranial NCC differentiation and craniofacial morphogenesis. Xversican and XHas2 exhibit overlapping expression also in the heart anlage, where these two ECM molecules seem to accomplish important functions as shown by the phenotypes exhibited both by Versican and Has2 null mice (Mjaatvedt et al., 1998; Camenisch et al., 2000) and by our previous observations following XHas2 abrogation in the early Xenopus embryo (Ori et al., 2006) .
In addition to the branchial pouches, Xversican transcript is detectable early on in other embryonic sites that later in development are colonized by trunk NCC, such as the pronephros, the pronephric duct and the heart. It has previously been suggested that during chick NCC migration through the trunk region versican may act as an "inversed haptotactic factor", that is an ECM factor that guides movement from a lower to a higher concentration of the factor, causing arrest of the cells at sites of peak concentrations of it Perris and Perissinotto, 2000) . Further functional studies in the Xenopus embryo are likely to clarify this mechanism still debated in literature.
Xversican transcription seems also to accumulate in signalling zones, such as the floor plate and the dorsal half of the notochord, suggesting that the PG may participate in inductive events controlling CNS development. On the whole the results add to our understanding of versican gene expression during early vertebrate development and further suggest that it may represent an ancestral PG with multiple evolutionary conserved functions and important tissue specific roles waiting to be further unveiled.
Materials and Methods
cDNA walking by 5'GENE RACE technology for full-lengh Xenopus laevis versican mRNA characterisation
We carried out the Xenopus laevis versican mRNA characterisation by the cDNA walking procedure and the 5'Gene Rapid Amplification of cDNA End method. Total RNA was extracted from stage 30 Xenopus laevis embryos using the Trizol reagent (Invitrogen, USA), according to manufacturer's instructions.
An EST clone containing a putative fragment of the Xenopus laevis versican gene has been initially identified by an in silico screening. The corresponding cDNA (clone XL078l14) was obtained from NIBB/NIG/ NBRP Xenopus laevis EST project (http://xenopus.nibb.ac.jp/). This clone was sequenced, aligned with human and chick versican sequences and used to design specific reverse oligos for the following 5'Gene Racer method (Fromhan, 1993) . The cDNA walking was conducted by using the 5' GENE RACE commercial kit (Invitrogen, USA), according to the supplier's instructions, with modified forward primers to obtain highly specific PCR products. Each PCR product was cloned using the TOPO TA Cloning for sequencing kit (Bernard et al., 1994) and the TOP 10 E. Coli competent cells (Invitrogen, USA), as suggested by the manufacturer. A 15 random selected clones were sequenced on both DNA strands, using the T3 and T7 internal oligos for sequencing and the ABI PRISM BigDye terminators cycle sequencing ready reaction kit (v. 1.1, Applied Biosystems, USA). The polynucleotides fragments obtained were separated by capillary electrophoresis on the ABI PRISM 310 Genetic Analyzer (Applied Biosystems, USA) and the electropherograms were analysed by the free ware Finch TV software (Geospiza, UK). The cDNA walking was always performed designing three new reverse oligos in the 5' end of the each newly identified nucleotide sequence.
In situ hybridization and immunohistochemistry
Xversican digoxygenin labelled antisense probe was transcribed from a partial cDNA clone corresponding to the region codifying for the EGF/ Lectin/CRP domains in order to be able to detect all the Xversican splice variant mRNAs. Embryos were staged according to Nieuwkoop and Faber (1967) . Whole-mount in situ hybridization was performed essentially as described by Harland (1991) . BM purple has been used as alkaline phosphatase substrates. Alternatively, tissue sections were obtained from embryos fixed 2 hours in 4% paraformaldeyde in PBS and subsequently cryo-protected with 20% sucrose in PBS. The 14 µm cryosections obtained were processed under stringent conditions (65°C, 50% formamide; washing solution 1x SSC, 50% formamide at 65°C) following the protocol reported in Strahle et al., (1994) , with minor modifications. Control experiments were performed with sense probes (data not shown). The XSox9 antisense probe was prepared according to Spokony et al., (2002) . For histological examination, whole-mount processed embryos were embedded in a gelatin albumin solution (0.5% gelatin and 30% albumin, both in PBS, pH 6) fixed with 0.6% glutaraldehyde, according to the protocol described in Levin (2004) , and then sectioned at 50 µm thickness using a Leica VT1000S Vibratome. Whole mount antibody staining was performed using an anti-muscle ATPase 12/101 monoclonal antibody (Developmental Studies Hybridoma Bank) following the procedure described in Ori et al., (2006) .
